T helper type 1 cell immune response (Th1 immune response)

The Th1 immune response refers to a functional subset of the adaptive immune system mediated by CD4+ T helper type 1 cells. These cells differentiate from naïve CD4+ T cells under the influence of cytokines such as IL‑12 and IFN‑γ. Once activated, Th1 cells secrete signature cytokines including interferon gamma (IFN‑γ), interleukin‑2 (IL‑2), and tumor necrosis factor alpha/beta (TNF‑α/β). These cytokines activate macrophages to kill intracellular pathogens like viruses and certain bacteria; they also promote the activation and survival of cytotoxic CD8+ lymphocytes[1][2][3][5]. The Th1 pathway is essential for effective defense against intracellular infections but can contribute to tissue damage in autoimmune diseases such as Crohn’s disease or organ-specific autoimmunity when dysregulated[5]. Markers associated with this lineage include surface proteins CCR5 and CXCR3 as well as transcription factors like T-bet and STAT4[1]. The “Th1 immune response” is not a single molecule or receptor but rather a coordinated cellular program; therefore it is not considered a direct therapeutic target itself but rather describes an immunological process or phenotype[2][3]. Note: This entry is marked is_incorrect = true because "Th1 immune response" describes an immunological process—not a discrete molecular target such as a receptor, enzyme, transporter, or protein. For structured data on drug targeting or molecular intervention purposes, individual components—such as IFN-gamma receptor or specific signaling molecules—should be used instead.

Other names

Th1 responseT helper 1 cell-mediated immunityType 1 T helper cell responseCell-mediated immunity (Th1)